Neurocognitive Disorders in our HIV Population
Valerie Wojna, MD

This presentation is designed to increase awareness of signs and symptoms of HIV-associated neurocognitive disorders and, identify differences between neurocognitive disorders and dementia. The participant will learn to administer tests/screens, and develop skills to be able to manage the condition in a primary care setting.
(Handouts/PDF)
(Slides/PPT)

Innate Immunity, CD4 Cell Count, and Elite Controllers
Savita Pahwa, MD

Human immunodeficiency virus (HIV) has as its main target the immune system. This session will cover the basics of immunology essential to understanding how HIV infection impacts the patient. Unique aspects of innate immunity and Elite Controllers will be discussed defining who are elite controllers vs. longterm nonprogressors and progressors. This session will introduce issues of care, monitoring, and treatment.
(Handouts/PDF)
(Slides/PPT)

Highlights from CROI
Ivan Meléndez-Rivera, MD, FAAFP, AAHIVS

This session reviews concepts of HIV care presented at the 2011 Retrovirus Conference. The audience will learn how to use the new information presented at major conferences in a way that would improve care of the patients infected with HIV.
(Handouts/PDF)
(Slides/PPT)

HIV and Cardiovascular Disease
Charurut Somboonwit, MD, FACP

HIV virus is an inflammatory agent by itself.  Along with the medications, there is evidence of increased cardiovascular risk. During this section, the participant will be able to identify the use of inflammatory markers as a predictor of cardiovascular disease, the effect of HAART suppression on activation markers, and more.  This lecture will highlight the newer biomarkers currently under investigation in the management of HIV.
(Handouts/PDF)
(Slides/PPT)

Prevention for Positives: How to Perform a Sexual History Interview
Carlos Rodriguez-Diaz, PhD, MPH, CHES

All patients with HIV infection should be screened for sexually transmitted diseases at baseline and annually; patients at increased risk should receive screening at 3- to 6-month intervals. Getting the information about sexual practices and habits can be a challenge based on the cultural and personal point of view. In this section, tools will be
discussed outlining different strategies to obtain an accurate sexual history.
(Handouts/PDF)
(Slides/PPT)

HIV and HCV: Current Management and New Developments
Dushyantha Jayaweera, MD, MRCOG (UK), FACP

This session will review evaluation for treatment of the co-infected patient, including: when to treat, selection of regimens, management of complications and side effects, as well as monitoring patients who fail treatment. This session will highlight the promise of emerging therapeutics and issues of selection of patients for transplant.
(Handouts/PDF)
(Slides/PPT)

Where Are We with HIV Vaccines?
Rafick Sekaly, PhD

The development of an HIV vaccine remains a challenge to HIV investigators. The speaker will discuss an update on the results from recent trials and future initiatives toward an HIV vaccine. He will discuss the challenges encountered in the development of HIV vaccines and what has been done so far to overcome some of these challenges. Finally, he will give his view of the possible vaccines that may be available in the future for prophylactic and therapeutic vaccines.
(Handouts/PDF)
(Slides/PPT)

HIV in Women, Pregnancy, Menopause, and Other Issues
Carmen D. Zorrilla, MD

Women living with HIV have special needs. Current methods of antiretroviral treatment during pregnancy have nearly eliminated the risk of vertical transmission, but it is important to optimize the patient’s health and time pregnancies appropriately to ensure the best maternal and neonatal outcomes.  Issues of aging in women will be presented from a preventive health format, including discussion of menopause management.
(Handouts/PDF)
(Slides/PPT)

Natural Immunity to HIV: Is There Hope for a Cure?
Hector Bolivar, MD

“Innate or Natural” immunity refers to immune responses that are present from birth and not learned, adapted, or permanently heightened as a result of exposure to microorganisms, in contrast to the responses of T and B lymphocytes in the adaptive immune system. During this section, components and functions of the innate immune system and their roles in possible HIV cures will be discussed.
(Handouts/PDF)
(Slides/PPT)

HIV and Aging
Luis A. Espinoza, MD, AAHIVS

Information from recent conferences will be reviewed on issues of aging in the HIV-infected population. The speaker will address the importance of patient education to reduce risk factors, as well as recommendations for monitoring, screening, treatment, and follow-up.
(Handouts/PDF)
(Slides/PPT)

Psychiatric Disorders in HIV
Glenn Treisman, MD

HIV is a changing epidemic with significant impact on psychiatry disorders due to multiple reasons (i.e. drugs abuse, medication side effects, and drugs interactions).  The challenge of the mental illness and patient population characteristics require a team approach using a multidisciplinary care for adequate management.
(Handouts/PDF)
(Slides/PPT)